Experimental validation and molecular docking to explore the active components of cannabis in testicular function and sperm quality modulations in rats
verfasst von:
Charles O. Nwonuma, Victoria C. Nwatu, Gomaa Mostafa-Hedeab, Oluyomi S. Adeyemi, Omokolade O. Alejolowo, Oluwafemi Adeleke Ojo, Sylvanus A. Adah, Oluwakemi J. Awakan, Charles E. Okolie, Nnaemeka Tobechukwu Asogwa, Inemesit A. Udofia, Godshelp O. Egharevba, Nada H. Aljarba, Saad Alkahtani, Gaber El-Saber Batiha
Data available support that ninety percent of male infertility cases are due to low sperm counts. There is a scarcity of data on the medicinal effects of cannabis on fertility. This study evaluated testicular function and sperm quality modulation with cannabis in rats.
Methodology
Twenty-five male Wistar rats were randomly grouped into five: A, B, C, and D, each group have 5 rats. A (control): 0.2 ml 2% DMSO, B (vitamin C): 90 mg/kg body weight, C, D, and E were administered: 5 mg/kg, 10 mg/kg and 20 mg/kg body weight of ethanolic leaf extract of cannabis (ELEC) respectively. The rats were sacrificed 24 h after the last day of the 60 day oral administrations. Flavonoids were the predominant phytochemical present in the extract while quercetin, kemferol, silyman and gallic acid were identified.
Results
The results showed a significant improvement (p < 0.05) in sperm quality and a significant increase in the concentrations of follicle-stimulating hormone, luteinizing hormone, triglycerides, cholesterol, and total protein determination compared to the normal control. Similarly, there was a significant increase (p < 0.05) in the activities of acid phosphatase, alkaline phosphatase, and superoxide dismutase compared to the normal control. RAC-alpha serine/threonine-protein kinase (AKT1)-silymarin complexes (-8.30 kcal/mol) and androgen receptor (AR)-quercetin complexes (9.20 kcal/mol) had the highest affinity.
Conclusion
The antioxidant effects of the flavonoids in the ethanolic extract of cannabis may have protected testicular and sperm cells from oxidative damage. Biochemical processes and histopathological morphology were preserved by cannabis. The docking prediction suggests that the bioactive principle of cannabis may activate the androgenic receptors. The androgenic receptor modulation may be attributed to silymarin and quercetin.
The original online version of this article was revised: the authors identified an error in the author name Inemesit A. Udofia, and Funding section statement.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ELEC
Ethanolic leaf extract of cannabis
cAMP
Cyclic adenosine monophosphate
AKT1
RAC-alpha serine/threonine-protein kinase
AR
Androgen receptor
HPLC
High Performance Liquid Chromatography
SF
Supplementary file
Introduction
Cannabis has medicinal benefit other than reported use for pain relief [1, 2]. However, the psychoactive component, tetrahydrocannabinol (THC), listed as a schedule-1 illicit drug in the United Nations' Single Convention on Narcotic Drugs has overshadowed the medicinal use of cannabis which has prompted it none approval by governments to be used for therapeutic purposes. As a consequence of the government's destruction of cannabis confiscated from illicit users in Nigeria and other countries across the globe, considerable amounts of money are lost annually [3]. With over 15.3 billion dollars invested, Nigeria has one of the largest numbers of cannabis users in the world. Furthermore, research into the alternative use of this substance may help to redirect this fund into productive use instead of destroying the substance [4]. Likewise, recent studies have shown that cannabis can increase the quality of sperm and so can be used to treat infertility [5]. Sperm cells and testicular tissues are prone to oxidative degeneration by environmental toxicants, which was reported to be responsible for infertility in human. However, because of the antioxidant constituents of medicinal plants such as cannabis, they can serve as alternative therapy for infertility in humans or animals.
Medicinal plants are robust repository of several antioxidants which makes them the alternative source for management of sexual dysfunction and other conditions associated with infertility [6]. Previous studies have shown that high phenolic and flavonoid compounds in plants are capable of scavenging free radicals, chelating metal-ion pro-oxidants and inhibiting some enzymes [7]. Cannabis sativa L., also known as hemp, is an annual herbaceous plant in the cannabis genus. The use of cannabis leaves for medicinal purpose dates back to the prehistoric times. It is thought to be one of the oldest medicinal herbs used by man. The testes are important male reproductive organs that are highly susceptible to toxic substances that can disrupt the blood-testis barrier, causing cell toxicity and, as a result, testicular dysfunction. The effect of these chemicals' inhibition can interfere with the synthesis and development of sperm cells, affecting the volume of sperm and its quality. Furthermore, estrogenic or anti-androgenic endocrine disrupting compounds may dominate the mechanism responsible for inhibiting the essential cellular process that controls the biosynthesis of testosterone in Leydig cells and androgen binding to the androgen receptor [8]. Because of the enormous medicinal value of cannabis leaf, with a focus on fertility enhancement, there is a need to scientifically validate the possible mode of action.
Anzeige
This research could lead to the discovery of a new drug that can be used instead of the current drug for the treatment of infertility. As a result, this study investigated the testicular function and sperm modulatory effect of ELEC in rats.
Materials and methods
Procurement and authentication of Cannabis
The dried cannabis leaves were obtained through an agreement with the National Drug Law Enforcement Agency (NDLEA) Ilorin Division. The leaf was authenticated at Ahmadu Bello University's Department of Botany in Zaria, Nigeria. It was given the voucher number ABU02438 and placed in the herbarium. All experimental protocols adhered to the ethical guidelines/regulations governing the use of plants.
Preparation of cannabis extract
The ELEC was prepared by soaking 1400 g of pulverized cannabis leaf in 2.8 L 90% ethanol in a beaker. The mixture was stirred in an orbital shaker for 2 h and; it is then left to stand for 24 h. Subsequently, the mixture was filtered; the filtrate was concentrated at 60 °C with a rotary evaporator for 15 min. The semi-fluid extract was dried at 40 °C using a water bath to dry weight and the percentage yield was 7.7% [9].
Quantitative phytochemical estimation
The phytochemical content of the plant sample was quantified spectrophotometrically by the respective method for each phytochemical form. The procedure by idumathi et al. [10] was used for the quantification of terpenoids. Furthermore, the quantities of alkaloids and glycosides were quantified by the methods described by Van-Burden and Robinson [11] and El-Olemy et al. [12] respectively. Flavonoids were described by the methods described by Bohm and Kocipai-Abyazan [13], while Kumar and Pandey [14] described the method for the quantification of Phenolics. Coumarins and steroids were quantified by the method described by Ejikeme et al. [15].
Anzeige
High Performance Liquid Chromatography (HPLC–UV) analysis
The HPLC analysis of ELEC was performed using a chromatographic system (N 2000, Korea) that included an Autosampler (YL 9150) with a 100 μl fixed loop and a UV–Visible detector (YL9120). At room temperature, the separation was performed on an SGE Protocol PC18GP120 (250mm4.6 mm, 5 m) column. The mobile phase is methanol to water (70:30 v/v), and the separations were accomplished using isocratic mode, with elution at a flow rate of 1 ml/min. The samples were run for 15 min, and detection was achieved using a UV detector at 254 nm. The autochro -2000 software was used to record and process all chromatographic data. Gallic acid, silymarin, quercetin, and kaemferol were used as standard samples for the analysis.
Animal procurement
Twenty-five male Wistar rats weighing 120–140 g were procured from the animal house of Department of Biochemistry, University of Ilorin. The rats were put in metal cages and were placed a well-ventilated space in the animal house of Landmark University and were allowed to acclimatize for seven (7) days before the experiment commenced. The animals were allowed access to their feed and water ad libitium.
Experimental design
The experimental animals were randomly assigned to 5 treatment groups: A, control: 2% DMSO was administered, B: 90 mg/kg body weight vitamin C was administered. Similarly, groups C, D and E were administered 5, 10 and 20 mg/kg body weight of ELEC, respectively. The dose used in this present study was a modification to a previous study by Alagbonsi et al. [16]
Animal euthanasia and collection of tissues
Following the experimental protocols for the handling of animals [17], the animals in this study were sacrificed 24 h after the last day of the 60-day experiment. The animals were euthanized after being anesthetized with 0.5 percent halothane and the jugular vein was then cut open to pump the blood into the sterilized sample container. Blood samples were further centrifuged at 5000 rpm for 5 min using a refrigerated centrifuge to separate serum. The serums collected were transferred to fresh sterile sample bottles and placed in the freezer before biochemical tests. The testes were taken from rats, homogenized, frozen and used for biochemical assays. A small portion of the tissue from the representative testes was cut and placed in 10% of the formal saline solution for histological examination.
Preparation of organs for biochemical analysis
The testicular tissue was homogenized in an appropriate buffer. The homogenate was further centrifuged at 5000 × g for 10 min. The supernatant was removed, frozen and used for biochemical assays.
Methods for the sperm analysis
The epididymis was harvested, quickly cleared of fatty tissue, and then weighed. The sperm per gram caudal epididymis was determined by weighing the caudal portion of the epididymis. 2010 WHO Manual was the reference used for the manual sperm examination [18]. Concentration was assessed using the Neubauer hemocytometer and the epididymal Sperm Concentration was counted by a modified method of Yokoi and Mayi [19]. Similarly, the Sperm Progressive Motility was evaluated by an earlier method by Sonmez et al. [20] Sperm count and sperm motility were evaluated at × 100 magnification under an Olympus light microscope equipped with a Makler counting chamber (Sefi-Medical Instruments, Haifa, Israel). Using an Olympus light microscope, two hundred sperm cells were examined at × 400 magnifications per animal to determine the morphological abnormalities. Olympus image analysis software was used for high-resolution 4-D acquisition through the light microscope.
Assay of serum testosterone, luteinizing hormone (LH), and follicle- stimulating hormone (FSH) level
The LH FSH and testosterone were quantified in the serum on the procedure based on a solid phase enzyme-linked immunosorbent assay (ELISA).
Biochemical assays
The method described by Kemp, A and Van Heijningen, AJ [21] was used to evaluate glycogen concentration, while the procedure described by Ilavarasan, R, Mallika, M [22] was followed for the determination of nitric oxide (NO) concentration. Rao and Ramakrishnan described the method used to evaluate 3-hydroxy-3-methylglutaryl-CoA reductase activity in the testis by measuring the ratio of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) and mevalonate concentration [23]. Superoxide dismutase (SOD) activity in the testicular homogenate was estimated by the method described by Misra, HP and Fridovich, I [24]. Jollow, DJ, Mitchell, JR [25] described the method used to evaluate reduced glutathione (GSH) level in the testis. The assay method described by Aebi [26] was used to evaluate catalase activity. The lipid peroxidation was estimated by the method described by Kei [27]. The total protein concentration was estimated by the method described by Gornall, AG, Bardawill, CJ [28]. (ACP) and alkaline phosphatase (ALP) activities were evaluated by the method described by Wright, P, Leathwood, P [29]
Anzeige
Tissue lipid extraction and estimation of concentration
Lipids in the freshly harvested testis were extracted following the method described by Folch, J, Lees, M [30]. The extracted mixture was further washed with 0.05 M KCl solution. Cholesterol and triglycerides were estimated in aliquots of chloroform–methanol extract. For the estimation of cholesterol concentration, 0.2 ml of the chloroform–methanol extract was evaporated to dryness at 60 °C. Furthermore, Triton X 100/chloroform mixture (1:1, v/v, 20 μl) was added to it to resolve the lipids and the solvent was evaporated again. 1 ml of cholesterol reagent from the kit (Spin React S.A., Santa Colona, Sant Esteve De Bas, Spain) was added to the evaporated extract, vortexed and left to incubate for 30 min at room temperature. Finally, the content of cholesterol was quantified spectrophotometrically [31]. Similarly, the concentration of triglycerides was determined in the chloroform–methanol extract according to the method described by Kriketos, AD, Furler, SM [32]. At 60 °C, an aliquot of the chloroform methanol extract was placed in Eppendorf tubes and allowed to evaporate to dryness. After allowing the dried extract to cool to room temperature, 97% of 200 ml of ethanol was added to the tube to re-suspend the triglyceride. 1 ml of the kit's triglycerides reagent (Spin React S.A., Santa Colona, Sant Esteve De Bas, Spain) was added to the evaporated extract, vortexed, and incubated at room temperature for 20 min. Triglyceride content was also measured spectrophotometrically. The plasma high-density lipoprotein (HDL-c) concentration was determined using the precipitation method, and the cholesterol concentration was estimated using a cholesterol kit.
Histopathology
The testes were extracted and immediately fixed in 10% of the formal-saline solution for histopathological analysis. The tissue samples were embedded in paraffin and then cut into a cross-section of 4–5 mm thickness and stained with hematoxylin–eosin. Histological sections were analyzed and photographed by Olympus BX50 (Japan) photo-microscope. A Leica slide scanner was used to view the slides (SCN 4000, Leica Biosystems, Germany).
Protein preparation
The molecular docking simulation study was carried out using the x-ray crystallographic structure of androgen receptor (AR) with the PDB code: 2Q7K and RAC-alpha serine/threonine-protein kinase (AKT1) with the PDB code: 3QKK. The crystal structures were curated by removing the bound ligands and water molecules as they are used to stabilize the protein structures with the help of AutoDock Tools version 1.5.6 [33]. Hydrogen atoms were added, Gasteiger charges added and saved for docking simulations.
Ligand preparation
In this investigation, the reference ligands that were used are capivasertib and testosterone. The choice of capivasertib is its ability to inhibit all isoforms of AKT, while testosterone is known to mediate its action through AR. The geometries of gallic acid, kaempferol, capivasertib, quercetin and silymarin were built and preoptimized at the molecular mechanics level with UFF Force Field, using the Steepest Descent algorithm implemented in Avogadro version 1.2.0. Further optimizations of the obtained ground state geometries were performed at the B3LYP/6–311 + G(2d,p) level of theory in the phase using Gaussian 16 RevC.01 by means of resources provided by SEAGrid [34] facilities. The optimized structures were converted to.mol2 format and used for molecular docking simulation study.
Anzeige
Molecular docking protocol
AutoDock Vina [35] was used for docking simulation. The docking parameters used for the 2Q7K-ligand simulation are: exhaustiveness = 20; center_x = 19.872083666, center_y = 7.17202171736 and center_z = 10.5685; size_x = 51.1804970921, size_y = 43.7164598852 and size_z = 53.5245303154. Similarly, the docking parameters used for the 3QKK-ligand simulation are: exhaustiveness = 20: center_x = 21.516, center_y = 2.3798 and center_z = 16.5016; size_x = 48.3612984443, size_y = 50.0442008591 and size_z = 59.6766584587. Throughout the docking experiment, the protein structures were kept rigid, while the torsions or degrees of freedom for the ligands were allowed full rotations. Nine conformational modes were obtained.
Data analysis
The data were expressed as the mean of three ± SEM determinations; one-way variance analysis (ANOVA) followed by post hoc Tukey to compare mean and assess significant differences between variables at p < 0.05 between the variables. All statistical analyses were carried out using the Social Science Statistical Package, version 22 (SPSS Inc. Illinois, Chicago, USA).
Results
The antioxidant phytochemical compounds, flavonoids, steroids, alkaloids, and phenolics were abundant in the ELEC (Table 1). The presence of gallic acid (0.0601 g/10 g), silymarin, (10.7060 g/10 g), quercetin (10.7060 g/10 g), kaemferol (10.7060 g/10 g), and unidentified compounds was revealed by HPLC analysis of flavonoids ( SF 1/ Table 1). When compared with the animals in the normal control group, there was a significant increase (p < 0.05) in sperm volume, concentration count, motile count, total sperm count, and percentage motility in the animals given vitamin C and ELEC doses (Table 2).
Table 1
Quantitative Phytochemical of ELEC and flavonoids compounds of HPLC
Phytochemicals
Quantity (mg/100 g)
Peak No
Peak ID
Ret Time
Height
Area
μg/10 g
Flavonoids
350.00 ± 0.17
1
Unidentified
0.107
5228.810
9588.600
0.0731
Steroids
292.96 ± 0.06
2
Gallic acid
0.840
1249.621
7881.600
0.0601
Alkaloids
138.32 ± 0.09
3
Unidentified
1.265
104.979
302.155
0.0023
Phenolic
113.80 ± 0.21
4
Silyman
1.407
1145.194
1789.270
10.7060
Coumarins
63.82 ± 0.01
5
Quercetin
2.715
274,110.781
5,833,277.50
44.4809
Terpenoids
13.92 ± 0.20
6
Unidentified
2.998
258,525.203
7,154,126.000
54.5528
7
Kaemferol
5.615
3489.348
108,164.719
0.8248
HPLC: High Performance Liquid Chromatography
Table 2
Effect of ethanolic leaf extract of cannabis on sperm parameters in Wistar rats
Group
Normal control
Vitamin C
5 mg/kg BW
10 mg/kg BW
20 mg/kg BW
Sperm volume (mL)
1.59 ± 0.08a
1.71 ± 0.01a
1.58 ± 0.10a
1.72 ± 0.02a
1.69 ± 0.04a
Concentration count (× 106 mL)
133.33 ± 6.67a
293.33 ± 6.67b
263.33 ± 13.33ab
183.33 ± 16.67c
216.67 ± 12.02d
Motile count (106 mL)
56.67 ± 3.33a
246.67 ± 3.33b
276.67 ± 3.33ab
176.67 ± 3.33c
173.67 ± 6.67c
Total count (× 106 mL})
193.33 ± 9.28a
504.33 ± 8.67b
442.00 ± 8.00c
317.00 ± 27.00ab
307.33 ± 30.67ab
Motility (%)
50.00 ± 0.00a
85.00 ± 1.00b
78.67 ± 12.86a
75.67 ± 14.33b
71.67 ± 14.33b
Fast
51.67 ± 3.33a
83.33 ± 0.88a
72.33 ± 9.59a
64.67 ± 12.99a
69.67 ± 13.45a
Slow
50.00 ± 4.53c
17.67 ± 2.88a
41.0000 ± 1.45b
51.0000 ± 1.00c
54.00 ± 2.08c
N
51.00 ± 2.08a
82.00 ± 2.00c
69.33 ± 11.39a
70.67 ± 12.99a
70.33 ± 13.86a
TD
22.67 ± 1.45c
8.00 ± 0.57a
11.67 ± 5.54a
13.33 ± 5.33a
13.00 ± 6.50a
ND
11.00 ± 0.57c
4.33 ± 0.33a
7.00 ± 3.05a
7.00 ± 3.00a
7.33 ± 3.84a
HD
13.00 ± 2.08b
5.00 ± 1.73a
6.67 ± 2.33a
6.00 ± 5.00a
7.33 ± 4.33a
The values are expressed as means of 3 replicates ± SEM
abcdp < 0.05 vs normal control
N Normal, TD Defected tail, ND Defected neck, HD Defected head
The number of fast-moving sperms was significantly higher (p < 0.05) in animals given vitamin C and the extract compared to normal control animals (Table 2). Similarly, animals given different doses of the extract and vitamin C had significantly (p < 0.05) more normal sperms than normal controls (Table 2). Rats in the treatment groups showed a greater percentage of weight change in the testis than did rats in the normal control group (Table 3). There was a significant increase (p < 0.05) in luteinizing hormone and follicle-stimulating hormone levels in the animals given the extract compared to the animals in the control and vitamin C groups (Fig. 1A and B). Furthermore, in comparison with the normal group, the rats administered the extract and vitamin C showed a significant decrease (p < 0.05) in testosterone levels (Fig. 1C). Furthermore, the HMG-CoA ratio decreased significantly (p < 0.05) in the animals administered the extract and normal control compared to the animals in the vitamin C group (Fig. 2A). Similarly, when compared with the vitamin C-treated group, the extract and normal control groups showed a significant increase (p < 0.05) in testicular cholesterol (Fig. 2B). Similarly, when compared to the normal control and vitamin C groups, there was a significant increase (p < 0.05) in testicular triglyceride levels in animals treated with the extract at lower doses (Fig. 2C). When compared with the animals in the vitamin C group, the serum HDL-c levels in the extract and normal control groups were significantly lower (p < 0.05) (Fig. 2D).
Table 3
The effect of ethanolic leaf extract of cannabis on the testicular weight change
Group
Initial weight
Final weight
% Weight change
Normal control
212.62 ± 13.62
218.14 ± 9.75
2.60 ↑
Vitamin C
211.00 ± 9.87
237.49 ± 11.18
12.60 ↑
5 mg/kg BW
199.67 ± 5.23
229.97 ± 7.29
15.16 ↑
10 mg/kg BW
198.33 ± 6.49
234.11 ± 15.74
18.04 ↑
20 mg/kg BW
208.33 ± 12.44
264.30 ± 16.08
26.90 ↑
The values are expressed as means of 3 replicates ± SEM
×
×
Anzeige
The percentage organ-body ratio of the testes was significantly lower in rats treated with the extract and vitamin C compared to the normal control (Fig. 3A). In contrast, when compared with the normal control, the testicular total protein was significantly increased (P < 0.05) in the animals treated with the extract (Fig. 3B). Similarly, the activities of ACP and ALP were significantly increased (p < 0.05) in the extract groups compared to the animals in the control group (Fig. 3 C and D). When compared to the normal control, the extract and vitamin C had no effect on glycogen concentration in rats (Fig. 2E). However, when compared to animals in the normal control group, cannabis leaf extract and vitamin C significantly increased (p < 0.05) nitric oxide concentration in the rat (Fig. 2F). When the extract groups were compared to the control groups, there was a significant increase (p < 0.05) in SOD and catalase activity (Fig. 3 E and F).
×
Similarly, there was a significant (p < 0.05) increase in GSH and malondialdehyde levels in the extract treated groups when compared to the normal control (Fig. 3 G and H). Furthermore, when compared to the normal control and vitamin C groups, the cell architecture of the testis of the animals treated with cannabis extract was normal, with no cell degeneration (Fig. 4 A-E). There are several types of interactions that determine ligand interactions with protein residues, among which are electrostatic interactions (hydrogen bonding), hydrophobic interactions, and halogen bonding.
×
AKT1 with silymarin and AR with quercetin have the best docking results, with binding energies of -9.40 and -9.20 kcal/mol, respectively, which are higher than capivasertib (-8.60 kcal/mol) and testosterone (-6.90 kcal/mol), the reference compounds (Table 4). The standard deviations are marginal, showing that each conformer does not greatly differ in their binding affinity. During the molecular docking experiment, the entire active space was sampled, and the pocket residues with constant binding interactions include LEU704, LEU707, and MET745 (Fig. 5A and B). The chemistry of interactions in AKT1-ligand complexes is dominated by conventional HB, electrostatic, and hydrophobic interactions, owing primarily to ASP292, GLU191, and THR195 (Fig. 5 C and D). The binding energy of AKT1- silymarin was -8.30 kcal/mol. and that of gallic acid was -5.90 kcal/mol, whereas the AR- quercetin complex binding energy was 9.20 kcal/mol. and that of AR- gallic acid was -5.60 kcal/mol. In general, ligands with AR have higher binding affinities than those with AKT1. Weak Van der Waals and hydrophobic interactions are the main interactions of testosterone, the reference compound for AR protein. TRP751, GLU681, and ARG752 were the pocket residues involved in these interactions but no hydrogen bonding interactions were observed. However, in addition to hydrophobic interactions, the AKT1 reference compound (capivasertib) is mediated by hydrogen bonding interactions.
Table 4
The binding energy, average binding energy of the nine conformational modes of each ligand
Protein
Ligand
Binding Energy (kcal/mol)
Average ΔG of ligand conformers (kcal/mol)
AKT1
Silymarin
-9.40
-9.00 \(\pm\) 0.27
Quercetin
-8.00
-7.56 \(\pm\) 0.24
Kaempferol
-7.60
-7.28 \(\pm\) 0.16
Gallic acid
-5.80
-5.47 \(\pm\) 0.21
Capivasertib
-8.60
-7.86 \(\pm\) 0.32
AR
Quercetin
-9.20
-8.06 \(\pm\) 0.69
Kaempferol
-9.10
-7.94 \(\pm\) 0.71
Silymarin
-8.20
-7.58 \(\pm\) 0.35
Gallic acid
-5.60
-6.13 \(\pm\) 0.27
Testosterone
-6.90
-6.59 \(\pm\) 0.19
AKT1 RAC-alpha serine/threonine-protein kinase, AR Androgen receptor
×
Discussion
Flavonoids have been widely reported to possess antioxidant potential which enables them to scavenge free radicals. The mechanisms of the antioxidant compounds are mainly by radical scavenging or metal ion chelation, and these activities are also based on configuration, substitution and the total number of hydroxyl groups. Flavonoids can also cause upregulation of antioxidant defense and can also inhibit reactive oxygen species (ROS) generation enzymes [36]. Furthermore, the optimal fertilizing capacity of the sperm cell will necessitate a controlled level of free radicals produced in the respiratory chain. As a result, a significant increase in the level of ROS would impede the upregulation of cyclic adenosine monophosphate (cAMP), which is responsible for the acrosome reaction; this would also result in lipid peroxidation of the sperm cell membrane and DNA fragmentation. Because of their antioxidant properties, vitamin C, Coenzyme Q, E, and glutathione are useful in the treatment of human infertility [37]. Previous studies have shown that the synergy of endogenous and exogenous antioxidant activity can reduce the effect of free radicals [38]. The increased flavonoid concentrations supported the antioxidant effect of this extract [39]. Similarly, previous research has shown that kaempferol and rutin provided antioxidant protection to sperm against ROS [40], which may be related to the study's improved sperm quality. This, in turn, resulted in improved sperm motility and viability. Sperm motility measures a sperm cell's ability to move properly across the vagina to the point where it can fertilize the ova, whereas insufficient sperm motility has been reported to be one of the most important parameters used to assess subfertility or infertility [41]. Furthermore, sperm viability and DNA fragmentation have been shown to contribute to fertility [42].
FSH represents the state of spermatogenesis as a result of feedback between the functions of the testis and the hypothalamus/pituitary glands. Spermatogenesis involves the interaction of hormones such as LH and FSH, which act on different cells of the testes due to the presence of their receptors: the FSHR is predominantly expressed in Sertoli cells, whereas the LHR is expressed in Leydig cells [43]. FSH acts on the Sertoli cell alone or in conjunction with testosterone to stimulate its proliferation and the production of signaling molecules and nutrients required for spermatid maturation [44]. As a result, the current study found increased levels of FSH and LH, indicating that cannabis extract may affect production. On the contrary, the extract appeared to reduce testosterone production in the Leydig cells, as evidenced by the lower serum testosterone levels reported in this study. The decrease in serum testosterone reported in this study, however, may not be below the threshold required for spermatogenesis. The high HMG-CoA/mevalonate ratio is an indicator of HMG-CoA reductase activity. The extract's increased reductase activity aided de novo synthesis of cholesterol, a precursor for testosterone and a building block for membranes in the testis. Furthermore, cholesterol is mobilized from HDL, although the extract did not alter the testicular HDL-c in this present study. One of the primary sources of cholesterol in testicular cells for the steroidogenic process is the cholesterol content of HDL-c [45]. Furthermore, triglyceride metabolism in the testes has been linked to male reproduction, potentially influencing spermatogenesis and sperm motility [46]. The increased triglyceride level in this study may have played a role in the improved sperm parameters.
The rise in MDA is a key indicator of lipid peroxidation. The dose-dependent increase in MDA could be due to the extract dosage used considering the long duration of this treatment, which could lead to accumulation in the tissue and thus predispose to oxidative stress. The ROS produced by this extract was superoxide anion, which explains the dose-dependent increase in SOD activity observed in this study. In the testes, SOD is a key antioxidant enzyme. It was reported to provide the first line of antioxidant enzyme protection against ROS. The inactivity of catalase reported in this study lends credence to the extract's antioxidant activity because the H2O2 produced by SOD did not increase the activity of CAT, implying that the H2O2 produced by SOD must have been scavenged by the extract's antioxidant function. The antioxidant effect of the extract could be the same reason for the higher level of GSH found in the study. The main source of energy to the testicular cells is glycogen. Glycogen found in Sertoli and spermatogonia cells nourishes the seminiferous tubule.
Glycogen content has also been reported to correlate with the levels of steroids [47]. In this study, the concentration of testicular glycogen was unaffected, indicating that the extract had no effect on glycogen synthesis in testicular cells. Meanwhile, nitric oxide synthase (NOS) activity has been reported in male reproductive organs [48]. Endothelial nitric oxide synthase is expressed in Sertoli and Leydig cells at various stages of spermatogenesis in testicular cells [49]. The increased nitric oxide activity may indicate that the extract increased the activity of the synthase. Furthermore, the reported decrease in testosterone levels in this study could be attributed to NO inhibition of testosterone synthesis in the Leydig cell [50]. The increased percentage weight change of the testis in this study could be due to the extract's protective effect against oxidative damage, which leads to cell death. The percentage of organ body weight is calculated by dividing the organ weight by the rat's weight and multiplying the result by 100. Because the percentage weight of the testes was normal, the decrease in the organ body weight ratio in this study was not associated with testicular cell death. However, this was due to the wide range of weights in the experimental animals. The testicular protein concentration refers to the total protein concentration in the testes, which includes enzymes involved in the physiological function of spermatogenesis and sperm cell differentiation [51]. The current study found an increase in total protein concentration, which could be an indication of the extract's effect. Furthermore, studies have shown that a change in ACP enzyme activity in matured testes along the spermatogenic cycle is also responsible for the maturation of spermatogonia to spermatozoa [52], and ACP activity has been reported to correlate with the number of germ cells present in the testis [53]. The increase in ACP activity reported in this study indicated an intact testicular cell that will later differentiate into normal and healthy sperm cells. The increase in ALP activity in this study also supported the extract's spermatogenic function. Sadik described ALP's spermatogenic function, which involves nuclear protein, nucleic acid, and phospholipid biosynthesis, phosphate ester cleavage, and mobilization of spermatogenic carbohydrates and lipid metabolites [50].
Because the Sertoli cell and spermatogonia cells host spermatogenesis, disruption of the cytoskeleton or degeneration of these testicular cells may affect sperm production [54]. The normal cell architecture of the testes reported in the current study lends credence to the antioxidant property of the extract or to the activation of a signaling pathway [55]. The signaling pathway caused by the interaction of silymarin and AKT1 could be the mechanism responsible for the improved sperm quality by cannabis extract. Signaling pathways are required for spermatogenesis to maintain a precise balance of cell survival, proliferation, and differentiation [56]. Furthermore, the increase in testicular weight is a function of germ and Sertoli cell proliferation and survival. In normal physiological conditions, AKT1 signaling regulates germ cell elimination via apoptosis, which may increase after testicular injury [57]. AR has been found in the nuclei of Sertoli, Leydig, and peritubular myoid cells in the testis, as well as epididymal epithelial and stromal cells [58]. Androgens are steroid hormones that are required for normal male reproductive development and function. Androgens act via AR, and its signaling in the testis is required for spermatogenesis [59]. The high binding energies of androgen receptor-quercetin or kempferol complexes could be a predictor of the mechanism for improved testicular function and sperm quality, according to the study, which also backed up a previous study that found kaempferol could improve mouse Leydig and Sertoli cell viability, male reproductive organ weights, and sperm quality [60].
Conclusion
Ethanolic leaf extract of cannabis has antioxidant properties that may have protected testicular cells and sperm cells from oxidative damage due to its high flavonoid content. In the same way, cannabis improved testicular biochemical processes and histopathological cell morphology. The activation of signal pathways in androgenic cells could be responsible for the improved sperm quality. The results of this study's docking indicate that cannabis' bioactive principle (s) may activate androgenic receptors, triggering a cascade mechanism required for testicular function and spermatogenesis. Silymarin and quercetin may be responsible for the androgenic receptor modulation.
Acknowledgements
Not applicable.
Declarations
Ethics approval and consent to participate
Ethical approval and license for the handling of experimental animals were obtained from the Ethical Committee of the Landmark University (LUAC/2020/0053B). The approval of the Institutional Ethical Committees was based on the guidelines of the World Health Organization for the care and use of laboratory animals. The study was carried out in compliance with the ARRIVE guidelines.
Consent for publication
Not Applicable.
Competing interests
Authors declare that there is no conflict of interest of any kind.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Experimental validation and molecular docking to explore the active components of cannabis in testicular function and sperm quality modulations in rats
verfasst von
Charles O. Nwonuma Victoria C. Nwatu Gomaa Mostafa-Hedeab Oluyomi S. Adeyemi Omokolade O. Alejolowo Oluwafemi Adeleke Ojo Sylvanus A. Adah Oluwakemi J. Awakan Charles E. Okolie Nnaemeka Tobechukwu Asogwa Inemesit A. Udofia Godshelp O. Egharevba Nada H. Aljarba Saad Alkahtani Gaber El-Saber Batiha